Related Experiment Video
Updated: Jun 6, 2026

Analysis of Cell Migration within a Three-dimensional Collagen Matrix
Published on: October 5, 2014
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization
1Rega Institute for Medical Research, Department of Microbiology and Immunology, K.U. Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium. sandra.liekens@rega.kuleuven.be
Stromal cell-derived factor-1 (SDF-1)/CXCL12 and its receptor CXCR4 are crucial in immune cell trafficking, tumor metastasis, and HIV entry. CXCR4 antagonists show promise for treating cancer, HIV, and mobilizing hematopoietic stem cells.
Area of Science:
- Immunology
- Oncology
- Virology
- Hematology
Background:
- Chemokines, such as stromal cell-derived factor-1 (SDF-1)/CXCL12, mediate leukocyte recruitment via G protein-coupled receptors like CXCR4.
- CXCL12/CXCR4 interactions are implicated in tumor growth, metastasis, inflammatory diseases, and HIV-1 infection.
- This pathway is vital for hematopoietic stem cell (HSC) migration and retention in the bone marrow.
Purpose of the Study:
- To discuss the biology of the CXCL12/CXCR4 axis.
- To review the development of CXCR4 antagonists.
- To explore their therapeutic potential in cancer, HIV, and stem cell mobilization.
Main Methods:
- Literature review of CXCL12/CXCR4 biology.
- Discussion of CXCR4 antagonist development.
- Analysis of preclinical and clinical data on therapeutic activities.
Main Results:
- CXCR4 expression is upregulated in tumors by hypoxia and VEGF, promoting metastasis.
- CXCR4 serves as a co-receptor for HIV entry into CD4+ T cells.
- CXCL12/CXCR4 signaling regulates HSC homing and bone marrow retention.
Conclusions:
- CXCR4 antagonists offer a potential therapeutic strategy against HIV-1 infection and CXCR4-expressing tumors.
- These antagonists can mobilize HSCs from the bone marrow for autologous transplantation.
- Targeting the CXCL12/CXCR4 axis presents a versatile therapeutic approach across multiple diseases.
More Related Videos
08:46Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix
Published on: August 14, 2016
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Regulation of Angiogenesis and Blood Supply
Cytoskeletal Coordination in Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Overview of Cell-Matrix Interactions